Cargando…
Denosumab-Induced Immune Hepatitis
Denosumab–Prolia®, Xgeva® (Amgen) is a fully human antibody to the receptor activator of the nuclear factor-K ligand (RANKL). Hepatotoxicity is extremely rare, with only one reported case of immune origin. We present a second case of hepatotoxicity resulting from an immune reaction to denosumab. A 4...
Autores principales: | Ostrovsky, Viviana, Malnick, Stephen, Ish-Shalom, Shahar, Ziv Sokolowskaia, Nadya, Yosepovich, Ady, Neuman, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830192/ https://www.ncbi.nlm.nih.gov/pubmed/33466886 http://dx.doi.org/10.3390/biomedicines9010076 |
Ejemplares similares
-
Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021) -
Checkpoint Inhibitors and Hepatotoxicity
por: Malnick, Stephen D. H., et al.
Publicado: (2021) -
Denosumab-induced alopecia areata with lichenoid eruption
por: Dourra, Mohsen, et al.
Publicado: (2021) -
Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
por: Jalleh, Ryan, et al.
Publicado: (2018) -
Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
por: Malnick, Stephen D. H., et al.
Publicado: (2021)